An illustrated review of bleeding assessment tools and common coagulation tests
暂无分享,去创建一个
[1] A. Paterson,et al. Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms , 2019, Research and practice in thrombosis and haemostasis.
[2] D. Garcia,et al. Diagnosis and Management of the Antiphospholipid Syndrome , 2018, The New England journal of medicine.
[3] D. Siegal,et al. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review , 2017, Chest.
[4] J. Baird,et al. Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample , 2015, PloS one.
[5] H. Husseinzadeh,et al. Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review , 2015, Journal of Thrombosis and Thrombolysis.
[6] P. James,et al. Generation and optimization of the self‐administered bleeding assessment tool and its validation as a screening test for von Willebrand disease , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[7] Shamim A. Mollah,et al. Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] C. Hayward,et al. Laboratory Investigations for Bleeding Disorders , 2012, Seminars in Thrombosis & Hemostasis.
[9] B. Coller,et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders , 2010, Journal of thrombosis and haemostasis : JTH.
[10] A. Tosetto,et al. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire , 2009, Journal of thrombosis and haemostasis : JTH.
[11] P. James,et al. Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand disease , 2008, Journal of thrombosis and haemostasis : JTH.
[12] A. Tosetto,et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD) , 2006, Journal of thrombosis and haemostasis : JTH.
[13] A. Tosetto,et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study , 2005, Journal of thrombosis and haemostasis : JTH.
[14] E. de Jonge,et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation* , 2004, Critical care medicine.
[15] L. Poller,et al. International Normalized Ratios (INR): the first 20 years , 2004, Journal of thrombosis and haemostasis : JTH.
[16] C. Kitchens. Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultation , 1988, American journal of hematology.
[17] A. Quick. The clotting time--an enigma resolved. , 1974, American journal of clinical pathology.